Search
Skip to Search Results- 2Proctor, Spencer (Agricultural, Food and Nutritional Science)
- 1Chan, Catherine B. (Agricultural, Food, and Nutritional Science/Physiology)
- 1Mager, Diana (Agricultural Food and Nutritional Science)
- 1Vine, Donna (Agricultural, Food and Nutritional Science)
- 1Wu, Jianping (Agricultural, Food, and Nutritional Science)
-
Blood Glucose-attenuating Effects of Pea-derived Fractions: Exploration of Mechanisms of Action in a Rat Model of Glucose Intolerance
DownloadFall 2015
Pulses, including dried peas, are nutrient-dense foods rich in fibre that have shown efficacy in improving glucose control in diabetic subjects. The seed coats, in spite of being the highly fibrous part, are sometimes discarded as a food-processing by-product. We hypothesized that supplementing...
-
Characterization of a novel model of intestinal lipoprotein overproduction and the impact of N-3 PUFA supplementation
DownloadFall 2009
Overproduction of intestinal chylomicrons (CM) has been proposed to contribute to fasting and post-prandial (PP) dyslipidemia and may accelerate the development of cardiovascular disease (CVD) during obesity, insulin resistance (IR) and diabetes. However, the impact of morphological changes in...
-
Effects of Egg White Derived Peptides on Metabolic Syndrome Complications: Hypertension, Inflammation, and Insulin resistance
DownloadSpring 2018
Metabolic syndrome (MetS), a cluster of several abnormalities of hypertension, inflammation, glucose intolerance and dyslipidemia, enhances a personâs risk for cardiovascular disease and type 2 diabetes. The number of people with MetS is increasing largely worldwide. The multi-faceted nature of...
-
Influence of dietary fat intake on acute changes in postprandial lipid and lipoprotein expression in children and adolescents with nonalcoholic fatty liver disease (NAFLD)
DownloadFall 2012
Nonalcoholic fatty liver disease (NAFLD) is a chronic liver disease that typically occurs in obese children and adolescents with hyperinsulinemia/insulin resistance and dyslipidemia. While treatment is aimed at lifestyle modification (diet and physical activity), very little is known regarding...
-
The role of ezetimibe and simvastatin in modulating intestinal cholesterol transport, chylomicron profile and chylomicron-remnant uptake by the arterial wall in a rodent model of the metabolic syndrome
DownloadFall 2010
Intestinally derived chylomicron remnants (CM-r) may contribute to atherogenic dyslipidemia during the Metabolic Syndrome (Mets). However, the combined effects of ezetimibe (EZ) and simvastatin (SV) on post-prandial (PP) dyslipidemia during MetS remains unclear, nor is it known whether the...